Percentage of γ < 2%/2mm within the 50% and 90% isodose volume regarding distance between target and metallic implants for one-arc, half-arc and two-arc VMAT plans of six patients.

Table 4: Percentage of γ _{< 2%/2 mm} within the 50% and 90% isodose volume regarding distance between target and metallic implants for one-arc, half-arc and two-arc VMAT plans of six patients.

Patient	Distance (cm)	γ _{< 2%/2 mm}
(target size (cm³)) [metal implant size (cm³)]		one-arc		half-arc		two-arc
(target size (cm³)) [metal implant size (cm³)]		50%	90%	50%	90%	50%	90%
Patient 1 (16.90) [4.8]	4.81	99.26	90.72	96.07	84.80	97.53	93.87
	3.31	99.19	90.92	94.72	79.48	95.84	89.07
	2.03	99.09	89.76	89.92	75.81	92.83	82.90
	1.06	98.64	84.37	87.11	74.45	93.46	80.38
Patient 2 (27.40) [2.6]	4.63	99.01	98.29	97.56	93.82	98.97	98.18
	3.76	98.26	96.32	97.10	92.73	98.71	97.52
	1.87	97.47	94.61	97.44	91.68	98.52	96.84
Patient 3 (29.50) [0.6]	12.65	99.48	99.60	99.18	99.25	99.32	99.39
	6.50	99.06	99.26	98.89	98.48	99.20	99.39
	4.29	98.75	97.92	98.68	97.57	99.26	99.30
	2.29	98.71	98.14	98.07	96.99	99.18	99.10
Patient 4 (18.50) [2.9]	4.07	98.89	98.59	98.70	97.46	99.14	98.97
	2.92	98.40	96.94	97.95	96.17	98.79	98.27
	2.11	98.31	97.09	97.08	94.18	98.85	98.32
	1.49	98.02	96.76	95.45	90.21	98.60	97.59
Patient 5 (51.77) [4.6] (24.12) [4.6]	6.66	97.07	95.84	94.98	91.19	97.30	96.54
	5.38	97.04	95.90	95.24	92.27	96.66	94.82
	4.37	96.95	95.88	95.41	91.99	96.89	95.59
	3.69	95.97	93.26	94.45	91.50	96.70	94.86
	6.16	96.74	94.54	96.92	94.14	97.57	97.57
	4.89	97.42	97.84	96.01	93.55	97.03	95.26
	3.74	96.30	94.91	96.03	93.97	96.84	94.32
	2.97	96.60	96.17	93.63	90.00	96.69	92.66
Patient 6 (45.65) [0.9] (22.37) [0.9]	4.25	98.62	97.92	97.33	98.19	99.07	99.06
	3.54	98.42	98.05	96.72	96.05	98.97	98.95
	2.85	97.46	97.19	96.17	96.80	98.22	98.85
	3.94	98.13	96.98	97.41	96.21	98.99	99.07
	3.38	97.32	94.15	95.81	95.21	98.83	98.82
	2.07	96.77	95.84	94.24	95.06	97.45	96.22